Related Experiment Video
Updated: Jun 28, 2026
Murine Model of Wound Healing
Published on: May 28, 2013
Study of wound healing in rats treated with topical and injected mitomycin C
Fernando de Andrade Quintanilha Ribeiro1, Lusiele Guaraldo, Janaina de Pádua Borges
1Department of Otolaryngology, Santa Casa School of Medicine, São Paulo, Brazil.
Objectives:
Mitomycin C, a widely used chemotherapeutic drug, has been proposed as a potential adjuvant for the control of scar tissue in surgical wounds because of its capacity to inhibit fibroblast proliferation. The current study used a combination of topical and injected mitomycin C to slow the healing process of surgical wounds in rats.
Methods:
An experimental model of surgical wounding at the dorsum of rats was used. A total of 43 animals were subdivided into 3 groups: control, topical mitomycin C, and a combination of topical treatment and intradermal injections of the drug at 30 and 60 days after the initial topical treatment. After 3 months, the animals were painlessly sacrificed and the surgical scars were removed for microscopic analysis.
Results:
The group that received only topical mitomycin C presented milder inflammatory signs and consequently had a less intense healing process than the control group. The group treated with a combination of both topical and injected mitomycin C presented results comparable to those of the control group.
Conclusions:
The toxic characteristics of mitomycin C were most likely responsible for the greater tissue damage that occurred when it was used in the injected form, causing increased scar tissue formation. Mitomycin C slows the healing process of surgical wounds when used topically, but causes enhanced scar tissue formation when injected.
